Skip to main content

Lisdexamfetamine Dimesylate Capsule Shortage

Last Updated: September 15, 2025
Status: Current

Unavailable, Current:

Limited Availability, Current:

Available, Current:

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Amneal Pharmaceuticals)

NDC Code: 65162-023-09
Availability: Unavailable
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-525-7270

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Lannett Company, Inc.)

NDC Code: 0527-4663-37
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Unavailable
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Amneal Pharmaceuticals)

NDC Code: 65162-024-09
Availability: Unavailable
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-525-7270

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Lannett Company, Inc.)

NDC Code: 0527-4664-37
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Amneal Pharmaceuticals)

NDC Code: 65162-025-09
Availability: Unavailable
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-525-7270

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Amneal Pharmaceuticals)

NDC Code: 65162-026-09
Availability: Unavailable
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-525-7270

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Amneal Pharmaceuticals)

NDC Code: 65162-027-09
Availability: Unavailable
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-525-7270

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Lannett Company, Inc.)

NDC Code: 0527-4667-37
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Unavailable
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Amneal Pharmaceuticals)

NDC Code: 65162-028-09
Availability: Unavailable
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-525-7270

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Apotex Corp.)

NDC Code: 60505-4739-1
Availability: Limited Availability
Status: Current
Date of update: September 11, 2025
Update type: Revised
Reason for shortage: Delay in shipping of the drug
Related Information: Next resupply date is late September 2025
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-046-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 10 mg (SpecGx LLC)

NDC Code: 0406-5111-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Lannett Company, Inc.)

NDC Code: 0527-4661-37
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Solco Healthcare US, LLC)

NDC Code: 43547-602-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Elite Laboratories, Inc.)

NDC Code: 64850-550-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0660-25
Availability: Limited Availability
Status: Current
Date of update: August 1, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 20 mg (SpecGx LLC)

NDC Code: 0406-5112-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0370-25
Availability: Limited Availability
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Lannett Company, Inc.)

NDC Code: 0527-4662-37
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Solco Healthcare US, LLC)

NDC Code: 43547-603-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Elite Laboratories, Inc.)

NDC Code: 64850-551-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-048-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-048-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 30 mg (SpecGx LLC)

NDC Code: 0406-5113-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0371-25
Availability: Limited Availability
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Solco Healthcare US, LLC)

NDC Code: 43547-604-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Elite Laboratories, Inc.)

NDC Code: 64850-552-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-049-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 40 mg (SpecGx LLC)

NDC Code: 0406-5114-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0372-25
Availability: Limited Availability
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Solco Healthcare US, LLC)

NDC Code: 43547-605-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Elite Laboratories, Inc.)

NDC Code: 64850-553-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-050-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 50 mg (SpecGx LLC)

NDC Code: 0406-5115-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0373-25
Availability: Limited Availability
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Lannett Company, Inc.)

NDC Code: 0527-4665-37
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Solco Healthcare US, LLC)

NDC Code: 43547-606-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Elite Laboratories, Inc.)

NDC Code: 64850-554-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3569-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-051-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 60 mg (SpecGx LLC)

NDC Code: 0406-5116-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0374-25
Availability: Limited Availability
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Lannett Company, Inc.)

NDC Code: 0527-4666-37
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: September 20, 2023
Contact info: 844-834-0530

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Solco Healthcare US, LLC)

NDC Code: 43547-607-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Elite Laboratories, Inc.)

NDC Code: 64850-555-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3570-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-052-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Additional supply anticipated early 2026
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Capsule, 70 mg (SpecGx LLC)

NDC Code: 0406-5117-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-325-8888

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0054-0375-25
Availability: Limited Availability
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Available on allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-631-2174

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Solco Healthcare US, LLC)

NDC Code: 43547-608-10
Availability: Limited Availability
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: On allocation
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 866-931-9829

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Elite Laboratories, Inc.)

NDC Code: 64850-556-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-852-6657

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-161-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Alvogen)

NDC Code: 47781-562-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6854-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 10 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3565-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-162-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Alvogen)

NDC Code: 47781-563-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Apotex Corp.)

NDC Code: 60505-4740-1
Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Related Information: Product currently available
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6855-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 20 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3566-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-163-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Alvogen)

NDC Code: 47781-564-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Apotex Corp.)

NDC Code: 60505-4741-1
Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Related Information: Product currently available
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6856-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 30 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3567-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-164-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Alvogen)

NDC Code: 47781-565-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Apotex Corp.)

NDC Code: 60505-4742-1
Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Related Information: Product currently available
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6857-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 40 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3568-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-165-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Alvogen)

NDC Code: 47781-566-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Apotex Corp.)

NDC Code: 60505-4743-1
Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Reverified
Related Information: Product currently available
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 50 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6858-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-166-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Alvogen)

NDC Code: 47781-567-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Apotex Corp.)

NDC Code: 60505-4744-1
Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Revised
Related Information: Product currently available
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 60 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6859-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Rhodes Pharmaceuticals L.P.)

NDC Code: 42858-167-01
Availability: Available
Status: Current
Date of update: August 5, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: January 11, 2024
Contact info: 888-827-0616

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Alvogen)

NDC Code: 47781-568-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Apotex Corp.)

NDC Code: 60505-4745-1
Availability: Available
Status: Current
Date of update: September 11, 2025
Update type: Revised
Related Information: Product currently available
Therapeutic category: Psychiatry
Initial posting date: November 1, 2023
Contact info: 800-706-5575

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Mylan Pharmaceuticals Inc., a Viatris Company)

NDC Code: 0378-6860-77
Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-796-9526

Lisdexamfetamine Dimesylate, Capsule, 70 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0480-3564-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-545-8800

Vyvanse, Capsule, 10 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-101-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Capsule, 20 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-102-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Capsule, 30 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-103-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Capsule, 40 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-104-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Capsule, 50 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-105-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Capsule, 60 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-106-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Capsule, 70 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-107-10
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer